SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,352.49 -83.80
(-0.80%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ICICI Bank Ltd

Industry : Banks - Private Sector

BSE Code

ISIN Demat

Book Value()

532174

INE090A01021

442.5412909

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ICICIBANK

18.18

892387.09

EPS(TTM)

Face Value()

Div & Yield %

68.53

0.88

Back

Concord Biotech consolidated net profit declines 15.07% in the December 2025 quarter

Feb 12,2026

Net profit of Concord Biotech declined 15.07% to Rs 64.48 crore in the quarter ended December 2025 as against Rs 75.92 crore during the previous quarter ended December 2024. Sales rose 13.74% to Rs 277.77 crore in the quarter ended December 2025 as against Rs 244.22 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	277.77	244.22	14
OPM %	35.38	40.11	-
PBDT	108.18	114.42	-5
PBT	89.44	101.15	-12
NP	64.48	75.92	-15

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,352.49 -83.80 (-0.80%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)